Published articles (2015):
1. Mobasseri M, Yavari A, Najafipoor F, Aliasgarzadeh A, Niafar M. Effect of a long-term regular physical activity on hypertension and body mass index in type 2 diabetes patients. J Sports Med Phys Fitness. 55(1–2):84–90.
2. Acute Pulmonary Edema in Patients with Cushing’s Syndrome. Adv Biosci Clin Med. 2015 Jan 1;3(1).
3. Rahal EA, Kazzi N, Nassar FJ, Matar GM. Escherichia coli O157:H7-Clinical aspects and novel treatment approaches. Front Cell Infect Microbiol. 2012;2:138.
4. Almasi S, Aliparasti MR, Aliasgarzadeh A, Abd-Nikfarjam B, Hyöty H, Knip M, et al. Investigation of CTLA-4-318C/T gene polymorphism in cases with type 1 diabetes of Azerbaijan, Northwest Iran. Immunol Lett. 2015 Aug;166(2):134–9.
5. Aliasgharzadeh A, Dehghan P, Gargari BP, Asghari-Jafarabadi M. Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: a randomised controlled clinical trial. Br J Nutr. 2015 Jan 28;113(2):321–30.
6. Ebrahimpour Koujan S, Gargari BP, Mobasseri M, Valizadeh H, Asghari-Jafarabadi M. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial. Phytomedicine. 2015 Feb 15;22(2):290–6.
7. Ostadrahimi A, Taghizadeh A, Mobasseri M, Farrin N, Payahoo L, Beyramalipoor Gheshlaghi Z, et al. Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Iran J Public Health. 2015 Feb;44(2):228–37.
8. Houshyar J, Bahrami A, Aliasgarzadeh A. Effectiveness of Insulin Glargine on Recovery of Patients with Diabetic Ketoacidosis: A Randomized Controlled Trial. J Clin Diagn Res. 2015 May;9(5):OC01-5.
9. Aghamohammadzadeh N, Niafar M, Dalir Abdolahinia E, Najafipour F, Mohamadzadeh Gharebaghi S, Adabi K, et al. The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients. Ther Adv Endocrinol Metab. 2015 Apr;6(2):56–60.
10. Niafar M, Nader ND. Adiponectin as serum biomarker of insulin resistance in patients with polycystic ovarian syndrome. Gynecol Endocrinol. 2015 Jun;31(6):473–6.
11. Sari-Sarraf V, Aliasgarzadeh A, Naderali M-M, Esmaeili H, Naderali EK. A combined continuous and interval aerobic training improves metabolic syndrome risk factors in men. Int J Gen Med. 2015;8:203–10.
12. Sadighi A, Bazavar M, Niafar M, Tabrizi A. Effect of metabolic syndrome on union rate of fractures. J Anal Res Clin Med. 2015 Mar 12;3(1):37–42.
13. Ebrahimi-Mamaghani M, Saghafi-Asl M, Pirouzpanah S, Aliasgharzadeh A, Aliashrafi S, Rezayi N, et al. Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome. J Health Popul Nutr. 2015 Mar;33(1):157–67.